AURKB and non-small cell lung carcinoma: Aurora B is elevated in a variety of human tumors and its over-expression is susceptible to tumor formation and poor outcomes of non-small cell lung cancer radiotherapy, therefore indicating that Aurora B might be a drug target for lung cancer [6,7,8].